Protara Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 90K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -90K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 13.5M | 13.1M | 9.6M | 10.8M | 9.1M | 9.5M | 8.1M | 6.4M |
| Operating Expenses | 19.5M | 19.1M | 14.8M | 16.6M | 14.1M | 14.3M | 12.3M | 10.7M |
| Operating Income | -19.6M | -19.1M | -14.8M | -16.6M | -14.1M | -14.3M | -12.3M | -10.7M |
| Other Income / Gains | 1.8M | 1.8M | 1.5M | 1.6M | 2.2M | 1.5M | 1.1M | 1.1M |
| Net Income | -17.8M | -17.3M | -13.3M | -15.0M | -11.9M | -12.8M | -11.2M | -9.5M |
| EPS (Diluted) | -0.42 | -0.38 | -0.31 | -0.35 | -0.29 | -0.48 | -0.50 | -0.45 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 6.1M | 6.0M | 5.2M | 5.8M | 5.0M | 4.8M | 4.3M | 4.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 6.1M | 6.0M | 5.2M | 5.8M | 5.0M | 4.8M | 4.3M | 4.3M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 19.6M | 19.1M | 14.8M | 16.6M | 14.1M | 14.3M | 12.3M | 10.7M |
| Interest Income | 1.8M | 1.5M | 1.5M | 1.6M | 1.7M | 1.1M | 1.1M | 1.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 90K | 93K | 88K | 98K | 83K | 82K | 84K | 83K |
| Ebitda | -17.7M | -17.2M | -13.2M | -14.9M | -11.8M | -12.7M | -11.1M | -9.4M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -17.8M | -17.3M | -13.3M | -15.0M | -11.9M | -12.8M | -11.2M | -9.5M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.42 | -0.38 | -0.31 | -0.35 | -0.29 | -0.48 | -0.50 | -0.45 |
| Weighted Average Shs Out | 42.8M | 46.0M | 42.3M | 42.3M | 40.7M | 26.4M | 22.3M | 21.2M |
| Weighted Average Shs Out Dil | 42.8M | 46.0M | 42.3M | 42.3M | 40.7M | 26.4M | 22.3M | 21.2M |